COMPASS Pathways plc (CMPS) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
33 Broadwick Street
London, W1F 0DQ
United Kingdom of Great Britain and Northern Ireland (the)
Phone
44 64 6905 3974
Website
Sector
Healthcare
Industry
Medical - Care Facilities
Employees
166
First IPO Date
September 18, 2020
| Name | Title | Pay | Year Born |
| Kabir Nath | Chief Executive Officer & Director | 1.07M | 1964 |
| Guy Goodwin | Chief Medical Officer | 632,409 | 1948 |
| Teri Loxam | Chief Financial Officer | 734,149 | 1973 |
| Benjamin Harber | Company Secretary | 0 | 1977 |
| Steve Levine | Chief Patient Officer | 0 | N/A |
| Lars Christian Wilde | Senior Advisor | 0 | 1986 |
| Susan C. Stansfield | Advisor | 0 | N/A |
| Michael Gold | Chief Research & Development Officer | 0 | 1961 |
| Stephen D. Schultz | Senior Vice President of Investor Relations | 0 | N/A |
| Lori Englebert | Chief Commercial Officer | 0 | 1978 |
COMPASS Pathways plc is a mental healthcare company with a primary presence in the United Kingdom and the United States. Established in 2020 and headquartered in London, UK, the firm focuses on developing novel treatments. Its key product is COMP360, an investigational psilocybin therapy. This therapy has advanced through Phase IIb clinical trials for treatment-resistant depression and is currently undergoing Phase II trials for post-traumatic stress disorder. The company previously operated under the name COMPASS Rx Limited before rebranding to COMPASS Pathways plc in August 2020.